The current analysis showed that the POLE mutation may be through the MMR, TGF-β, and RTK/RAS/RAF signaling pathways affecting tumor development, while the POLD1 mutation may affect tumor development through the MMR signaling pathway [55]. This evidence concerns the gene POLD1 and neoplasm.